What is the appropriate oral isotretinoin dosage for a 45‑kg patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Oral Isotretinoin Dosage for 45kg Patient

For a 45kg patient with severe acne, start isotretinoin at 22.5 mg daily (0.5 mg/kg/day) for the first month, then increase to 45 mg daily (1 mg/kg/day) thereafter, targeting a cumulative dose of 5,400-6,750 mg (120-150 mg/kg). 1, 2

Dosing Algorithm by Acne Severity

Severe Acne (Nodular/Cystic)

  • Initial dose: 0.5 mg/kg/day = 22.5 mg daily (first month)
  • Maintenance dose: 1.0 mg/kg/day = 45 mg daily (subsequent months)
  • Target cumulative dose: 120-150 mg/kg = 5,400-6,750 mg total
  • Duration: Approximately 4-5 months at full dose 1

Rationale: Patients treated with 1.0 mg/kg/day have significantly lower relapse rates compared to 0.5 mg/kg/day, and cumulative doses of 120-150 mg/kg optimize long-term remission 1. The dose-dependent therapeutic benefit plateaus beyond 150 mg/kg 1.

Moderate Acne (Treatment-Resistant or Scarring)

  • Daily dose: 0.25-0.4 mg/kg/day = 11-18 mg daily
  • Duration: 6+ months
  • Cumulative dose: Less critical than in severe acne 1, 3

Key distinction: Low-dose regimens in moderate acne show equal relapse rates to conventional dosing, unlike severe acne where higher doses reduce relapses 1.

Critical Administration Details

Food Requirement

  • Must be taken with meals to ensure adequate absorption 1, 2
  • Failure to take with food significantly decreases absorption 2
  • Exception: Lidose-isotretinoin formulation can be taken without food 1

Divided Dosing

  • Give in two divided doses daily with food 2
  • Once-daily dosing safety not established and is not recommended 2

Practical Dosing for 45kg Patient

Month 1: 10 mg capsule twice daily (20 mg/day total) OR 20 mg once daily with largest meal Months 2-5: 20 mg capsule twice daily (40 mg/day total) OR adjust to 45 mg if available formulations allow

Common Pitfalls to Avoid

  1. Don't use intermittent dosing (e.g., 1 week per month) - associated with higher relapse rates 1
  2. Don't base dose adjustments on weight changes during treatment - use starting weight throughout unless extreme weight change occurs 4
  3. Don't stop early - completing the full cumulative dose is critical for severe acne to minimize relapse 1
  4. Don't skip the food requirement - this is the most common reason for treatment failure due to poor absorption 2

Monitoring Requirements

  • Baseline: Liver function tests, lipids (cholesterol, triglycerides) 1, 2
  • Follow-up: Repeat labs until response established 1
  • CBC monitoring: Not needed in healthy patients 5, 1
  • Pregnancy prevention: Mandatory for all patients of childbearing potential with iPLEDGE compliance 5, 1, 2

When to Adjust Dosing

Increase dose (up to 2 mg/kg/day = 90 mg/day for 45kg patient):

  • Very severe disease with scarring
  • Disease primarily on trunk
  • Only after confirming compliance with food intake 2

Decrease dose (or start lower):

  • Extremely severe cases (may need 0.25 mg/kg/day with concurrent oral steroids) 1
  • Intolerable mucocutaneous side effects
  • Significant lipid elevations

Duration and Retreatment

  • Typical course: 15-20 weeks at full dose 2
  • May discontinue early if >70% nodule reduction achieved before 15-20 weeks 2
  • Retreatment: Wait minimum 2 months off therapy before considering second course 2

The 2024 AAD guidelines conditionally recommend traditional daily dosing over intermittent dosing for severe acne 5, reinforcing that consistent daily administration optimizes outcomes for this 45kg patient.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.